Saleem A. Farooqui

Statistics

Publications

Citations

214

H-Index

Active since

2021

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

George Washington University

University Hospital Münster

Oregon Health & Science University

Saleem A. Farooqui is an author at Pfizer (United Kingdom) specializing in atopic dermatitis pharmacotherapy, dermatology, and atopic dermatitis treatment.

Publications per year

2021–2023

Publications

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program

Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum et al. · American Journal of Clinical Dermatology · 2021 · 139 citations · Full text

Medicine, Dermatology, Pharmacology +14

Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study

Kristian Reich, Jonathan I. Silverberg, Kim Papp et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 42 citations · Full text

Medicine, Dermatology, Pharmacology +13

High threshold efficacy responses in moderate‐to‐severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents

Sonja Ständer, Neal Bhatia, Melinda Gooderham et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 17 citations · Full text

Medicine, Dermatology, Pharmacotherapy +11

Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies

Brian Kim, Jonathan I. Silverberg, Sonja Ständer et al. · Dermatitis · 2021 · 16 citations · Full text

Medicine, Dermatology, Pharmacology +16

1–4 of 4